A severe case of Trichophyton rubrum-caused dermatomycosis exacerbated after COVID-19 vaccination that had to be differentiated from pustular psoriasis
2022
Norimatsu, Yuta | Norimatsu, Yurie
We present a case of deep dermatomycosis caused by Trichophyton rubrum that developed after administration of SARS-CoV-2 BNT162b2 vaccination. A 75-year-old man was vaccinated with SARS-CoV-2 on day 0 and day 23. From day 25, pustules began to appear. A skin biopsy was performed. Tissue culture revealed the presence of Trichophyton rubrum. The patient was treated with topical luliconazole and 100 mg/day oral fosravuconazole for 84 days, after which the symptoms resolved.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
Elsevier B.V.
其它主题
Bnt162b2; Trichophyton rubrum; Dermatomycosis; Pustular psoriasis; Fosravuconazole; Sars-cov-2 vaccination; Psoriasis; Covid-19 infection; Luliconazole
语言
英语
许可
//data.crossref.org/schemas/AccessIndicators.xsd:license_ref>http://purl.org/eprint/accessRights/OpenAccess | //data.crossref.org/schemas/AccessIndicators.xsd:program>//data.crossref.org/schemas/AccessIndicators.xsd:license_ref> | //data.crossref.org/schemas/AccessIndicators.xsd:program>
类型
Journal Article; Text
2024-02-28
2026-02-03
MODS